ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

Elevai Labs, Inc. is pleased to announce it has signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio, Inc. The licensing agreement grants Elevai a license to use INmune Bio’s proprietary “EMx” technology that enables Elevai to manufacture current Good Manufacturing Practice grade, human umbilical cord-derived MSCs at a lower cost to Elevai than purchasing hucMSCs outright.